title: Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
authors.affiliation: Department of Hematology, Oncology, and Tumor Immunology, University Medical Center Charité, Humboldt University, 13125 Berlin, Germany.
authors.forename: Bernhard
authors.initials: B
authors.lastname: Gillissen
authors.forename: Jana
authors.initials: J
authors.lastname: Wendt
authors.forename: Antje
authors.initials: A
authors.lastname: Richter
authors.forename: Anja
authors.initials: A
authors.lastname: Richter
authors.forename: Annika
authors.initials: A
authors.lastname: Müer
authors.forename: Tim
authors.initials: T
authors.lastname: Overkamp
authors.forename: Nina
authors.initials: N
authors.lastname: Gebhardt
authors.forename: Robert
authors.initials: R
authors.lastname: Preissner
authors.forename: Claus
authors.initials: C
authors.lastname: Belka
authors.forename: Bernd
authors.initials: B
authors.lastname: Dörken
authors.forename: Peter T
authors.initials: PT
authors.lastname: Daniel
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002277:Carcinoma / Q000378:metabolism*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D006801:Humans; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism* / Q000494:pharmacology; D050998:bcl-2 Homologous Antagonist-Killer Protein / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051028:bcl-2-Associated X Protein / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism*; D051020:bcl-X Protein / Q000378:metabolism*
chemical_list: C494772:BAK1 protein, human; D064549:Myeloid Cell Leukemia Sequence 1 Protein; D019253:Proto-Oncogene Proteins c-bcl-2; D053221:TNF-Related Apoptosis-Inducing Ligand; D050998:bcl-2 Homologous Antagonist-Killer Protein; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein